Simplex Trading
QNCX icon

Simplex Trading’s Quince Therapeutics QNCX Stock Holding History

Simplex Trading’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,631
Closed -$32.9K – 10117
2026
Q1 		$32.9K Buy
1,631
+1,264
+344% +$254K ﹤0.01% 6293
2025
Q4 		$246K Buy
367
+286
+353% +$144K ﹤0.01% 4018
2025
Q3 		$26K Sell
81
-68
-46% -$22.6K ﹤0.01% 7108
2025
Q2 		$49K Sell
149
-23
-13% -$5.26K ﹤0.01% 5940
2025
Q1 		$45K Sell
172
-79
-31% -$24.1K ﹤0.01% 5880
2024
Q4 		$93K Buy
251
+224
+830% +$67.3K ﹤0.01% 5245
2024
Q3 		$4K Buy
+27
New +$3.87K ﹤0.01% 7760
2023
Q4 		– Sell
-109
Closed -$24K – 9622
2023
Q3 		$24K Hold
109
– – ﹤0.01% 6479
2023
Q2 		$32K Sell
109
-23
-17% -$7.16K ﹤0.01% 6299
2023
Q1 		$41K Buy
132
+3
+2% +$587 ﹤0.01% 6151
2022
Q4 		$16K Buy
129
+18
+16% +$3.01K ﹤0.01% 7095
2022
Q3 		$29K Sell
111
-37
-25% -$14.1K ﹤0.01% 7115
2022
Q2 		$65K Sell
148
-138
-48% -$97.5K ﹤0.01% 6151
2022
Q1 		$354K Buy
286
+50
+21% +$68K ﹤0.01% 4309
2021
Q4 		$595K Sell
236
-6
-2% -$36.6K ﹤0.01% 3562
2021
Q3 		$2.67M Hold
242
– – ﹤0.01% 1801
2021
Q2 		$2.56M Buy
242
+240
+12,000% +$2.01M ﹤0.01% 1852
2021
Q1 		$1.36M Buy
+2
New +$14.4K ﹤0.01% 2070
2020
Q4 		– Hold
0
– – – 5603

Other funds holding QNCX

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's QNCX Position: Q2 2026 in Review

Simplex Trading sold out of Quince Therapeutics (QNCX) in Q2 2026, closing a stake of 770 shares — an estimated $15.6K sold.

Simplex Trading first reported a position in QNCX in Q3 2020 and held it in 10 quarters. The position peaked at $560K in Q4 2025. 27 funds tracked by Wall St. Rank hold QNCX as of Q2 2026.

  • Simplex Trading reported no remaining Quince Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 770 Quince Therapeutics shares in Q2 2026, an estimated $15.6K.
  • Simplex Trading first reported a position in Quince Therapeutics in Q3 2020 and held it in 10 quarters.
  • Simplex Trading's Quince Therapeutics position peaked at $560K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.